ASM is pleased to support Antibiotic Action which brings together stakeholders from across the globe to look at how we stimulate industry R&D in antibacterial discovery and development?, reports David Hooper MD, President of ASM ?Infectious diseases are a significant cause of illness and economic loss in the US, UK and worldwide and new diagnostics and therapeutics are urgently needed to stem, control and treat them. It is through initiatives such as this that we can stimulate debate, raise awareness and hopefully make the difference that is needed?.





